ASHM Report Back
Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
HPV, HIV & Anal Cancers in MSM
Notes from talk stream:
Men who have sex with men are at significant risk of HPV related anal cancers. HIV negative MSM are at an estimated 20-40x risk and HIV positive MSM are at 100x risk!
HPV Vaccination is going to be one of the keys to help reduce this risk.
Many gay men have not been vaccinated for HPV and this is a key move that can help reduce incidence.
Many doctors are not doing DRE to examine for any anal lumps.
It's a simple, cheap and easy exam and can detect early anal cancers from 0.5cm diameter.
Early detection <1cm results in simple surgical treatment that may not require chemo/radiation therapy.
HIV positive men should be offered annual DRE and HIV neg MSM every 1-3 years.
Anal Paps are difficult to fully roll out at the moment as many early anal changes will self regress. Sadly anal colposcopy services are very limited currently making this one area of bottle neck in evaluation of early anal lesions.
This session has absolutely changed the way I will be practicing and caring for my MSM patients from today!
Good resource for futher information for both doctors and clients is this site created by AFAO.